Stay updated on SGN-PDL1V in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Hepatocellular carcinoma was added to the list of conditions, and the page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:11:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:46:55.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added hepatocellular carcinoma, endometrial cancer, and pancreatic adenocarcinoma as study indications; updated the study locations to 61 sites.
    Difference
    2%
    Check dated 2026-02-25T18:36:26.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added Gastric cancer as a study condition. Removed government funding lapse notice and updated page revision to v3.4.2.
    Difference
    0.3%
    Check dated 2026-02-11T14:11:58.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a government-funding lapse notice about possible delays and updates the site revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:18:07.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added a Show glossary option and new meta-information fields: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. Removed or replaced items include Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T05:57:38.000Z thumbnail image

Stay in the know with updates to SGN-PDL1V in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SGN-PDL1V in Advanced Solid Tumors Clinical Trial page.